←
Hiten Patel736 posts
Hiten Patel avatar

Hiten Patel

@HitenDPatel

Urologic Oncologist @NM_Urology & @ChicagoVAMC @WUSTL, @HopkinsMedicine, @JohnsHopkinsSPH, @brady_urology, @LoyolaUrology @UroOnc Views are my own. #BLM

◷ Joined July 2012▧ 61 Photos and videos
Tony Su avatar
⟳ Hiten Patel retweeted
Tony Su@ztonysu·Oct 20

Thx to @JAMANetworkOpen for publishing our cost-effectiveness study of periop EV-pembro for cisplatin-ineligible MIBC @MaxKates @SBoorjian @tbivala1 @m_e_nielsen @siadaneshmand @SHPatelMD1 @nirmishsingla @JCensits @akfsurgeon @Sood11 @HitenDPatel @RuchikaTalwarMD @brady_urology

For cisplatin-ineligible muscle-invasive #BladderCancer, perioperative #EnfortumabVedotin plus pembrolizumab with radical cystectomy was associated with improved survival and was cost-effective vs radical cystectomy alone over 10 years. ja.ma/4seltqJ

Post attachment
Abhishek A. Solanki, MD MS avatar
⟳ Hiten Patel retweeted
Abhishek A. Solanki, MD MS@abhiAsolanki·Oct 5

1/5: I am excited to share that VA STARPORT completed recruitment on Friday October 2, 2026. I am thankful to the Veterans who participated in the study and to our investigators and research teams across the VA who put in an incredible amount of work to get us here. @VAResearch

Post attachment
Prostate Cancer Foundation avatar
⟳ Hiten Patel retweeted
Prostate Cancer Foundation@PCFnews·Oct 4

The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most. For 33 years, PCF has brought science and lived experience together to move research forward. #PCFRetreat26

Post attachment
Andrew Gabrielson avatar
⟳ Hiten Patel retweeted
Andrew Gabrielson@urogabe·Sep 22

Oral boards prep hasn't appreciably changed in decades, so I built MockUro, an AI examiner that walks you through ~250 canonical urology cases in Socratic Q&A format, grades your free-form answers across key domains, and adapts your study plan to your weak spots 🧵

0:30
Matt Cooperberg avatar
⟳ Hiten Patel retweeted
Matt Cooperberg@dr_coops·Jun 2

And just like that, an era ended. Neoadj chemo before cystectomy is now a historical footnote #ev304 #keynoteb15 #ASCO26

PRACTICE CHANGING: #KEYNOTEB15/EV304- in #MIBC, periop EV/P led to sig EFS (NR v 48.5m, 24m EFS 79.4 v 66.2%, HR0.53; 0.41-0.7), OS (NR v NR, 24m estimated OS 86.9 v 81.3%, HR 0.65; 0.48-0.89), pCR  (55.8 v 32.5%) benefit v. neoadj gem/cis, supporting EV/P as SOC in this setting

Post attachmentPost attachmentPost attachmentPost attachment
NEJM avatar
⟳ Hiten Patel retweeted
NEJM@NEJM·May 12

New in our partnership with @DGlaucomflecken: the KEYNOTE-905 trial evaluated enfortumab vedotin plus pembrolizumab as perioperative therapy in patients with muscle-invasive bladder cancer who were ineligible to receive cisplatin. Read the full study for free: nej.md/DrG40

1:06
NM Urology avatar
⟳ Hiten Patel retweeted
NM Urology@NM_Urology·May 11

#AUA26 is just 4 days away! @NorthwesternMed Urology will be strongly represented at this year’s Annual Meeting by our faculty, residents, fellows, and medical students. We’re excited to share our work—and to connect with colleagues from around the world. Meet our representatives and follow along for conference updates!

Post attachment
NM Urology avatar
⟳ Hiten Patel retweeted
NM Urology@NM_Urology·Apr 8

🚨 PUBLICATION ALERT 🚨 Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implications Authors included: Ashley Ross, MD, PhD, Edward Schaeffer, MD, PhD (@EdwardSchaeffer), Hiten Patel, MD (@HitenDPatel), Jamie Michael, MD, Nicole Handa, MD Publication link: nature.com/articles/s41698-0…

Post attachment
Hiten Patel avatar
Hiten Patel@HitenDPatel·22 Oct 2025

Purple = prostate peripheral zone, Green = prostate transition zone, White = seminal vehicles, Brown = PANIC, Yellow = bladder, Orange = Tumor and cytokines

Yahoo Sports avatar
⟳ Hiten Patel retweeted
Yahoo Sports@YahooSports·18 Oct 2025

ARE WE WITNESSING THE BEST INDIVIDUAL PERFORMANCE EVER IN THE POSTSEASON ⁉️ 🧊 3 HR 🧊 6 scoreless IP 🧊 10 Ks SHOHEI OHTANI IS REALLY HIM 🐐

Post attachment